Full text
Earnings transcript
Read the complete earnings call transcript.
XYL
Xylem Inc.
$102.54
-0.05
(-0.05%)
| Exchange: | NYSE |
| Market Cap: | 23.942B |
| Shares Outstanding: | 184.6M |
Delayed data
About The Company
| Sector: | IndustrialsView sector performance | |||||
| Industry: | Industrial – MachineryView industry performance | |||||
| CEO: | Matthew F. Pine | |||||
| Full Time Employees: | 22000 | |||||
| Address: |
| |||||
| Website: | https://www.xylem.com |
Xylem Inc., together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions for utility, industrial, and residential and commercial building services settings worldwide. It operates through Water Infrastructure; Applied Water; Measurement and Control Solutions; and Water Solutions and Services segments. The company offers water, wastewater, and storm water pumps and controls and systems; filtration, disinfection, and biological treatment equipment under the Flygt, Ionpure, Leopold, Neptune Benson, Sanitare, Wallace & Tiernan, and Wedeco brands; and pumps, valves, heat exchangers, controls, and dispensing equipment used for water and focuses on the residential, commercial and industrial markets under the Rule, Bell & Gossett, Flojet, Goulds Water Technology, Jabsco, and Lowara brands. It also provides smart meters, network communication devices, data analytics, test instruments, controls, sensor devices, software and managed services, critical infrastructure services, cloud-based analytics, and remote monitoring and data management under the Ebro, Sensus, Sentec, Smith Blair, WTW, YSI, and Xylem Vue brands. In addition, the company offers preventative maintenance services, rapid response mobile services, digitally enabled/outsourced solutions, process and wastewater treatment systems, environmental remediation, odor and corrosion control, filtration, reverse osmosis, continuous deionization, and mobile dewatering equipment and rental services; and municipal services comprising odor and corrosion control services, as well as condition assessment and asset management, and pressure monitoring solutions under the Grindex, Mar Cor, and Godwin brands. Xylem Inc. was formerly known as ITT WCO, Inc. and changed its name to Xylem Inc. in July 2011. The company was incorporated in 2011 and is headquartered in Washington, District Of Columbia.
Click to read more…
Revenue Segmentation
XYL full analysis
Welcome to MARKETSNAP’s SWOT analysis for Xylem Inc., also known by its ticker XYL. If you’re a long-term investor looking to build wealth through smart stock picks, you’re in the right place. Today, we’re diving deep into Xylem, a company that might not be a household name like some tech giants, but it’s a major player in a critical industry. Let’s break down what makes this company tick, look at recent developments, and analyze its potential through a comprehensive SWOT…
EPS
Historical EPS and analyst estimates in one chart. Log in for the full interactive view and links to detailed estimates.
Earnings Call
AI summary
Key takeaways
Short, structured highlights from the call so you can focus on what matters.
Log in to continue
Log in to read the full transcript and AI-generated earnings summaries.
Login — it's freeIncome Statement
| Year | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | 7,364,000 | 8,562,000 | 9,035,000 |
| Gross Profit | 2,717,000 | 3,212,000 | 3,475,000 |
| EBITDA | 1,120,000 | 1,693,000 | 1,785,000 |
| Operating Income | 652,000 | 1,009,000 | 1,223,000 |
| Net Income | 609,000 | 890,000 | 957,000 |
(* All numbers are in thousands)
Balance Sheet
| Year | 2023 | 2024 | 2025 |
|---|---|---|---|
| Total Assets | 16,112,000 | 16,493,000 | 17,634,000 |
| Total Liabilities | 5,936,000 | 5,615,000 | 5,885,000 |
| Total Stockholders Equity | 10,166,000 | 10,642,000 | 11,480,000 |
| Total Debt | 2,390,000 | 2,125,000 | 1,942,000 |
| Cash and Cash Equivalents | 1,019,000 | 1,121,000 | 1,479,000 |
(* All numbers are in thousands)
Cash Flow Statement
| Year | 2023 | 2024 | 2025 |
|---|---|---|---|
| Operating Cash Flow | 837,000 | 1,263,000 | 1,241,000 |
| Capital Expenditure | -271,000 | -321,000 | -331,000 |
| Free Cash Flow | 566,000 | 942,000 | 910,000 |
| Net Income | 609,000 | 890,000 | 950,000 |
| Net Change in Cash | 75,000 | 102,000 | 358,000 |
(* All numbers are in thousands)
Analyst Estimates
| Fiscal Year | 2030 | Research Access | Research Access | Research Access | Research Access |
|---|---|---|---|---|---|
| Estimated Revenue (Low) | 10,813,673.045 | Research Access | Research Access | Research Access | Research Access |
| Estimated Revenue (High) | 11,227,331.838 | Research Access | Research Access | Research Access | Research Access |
| Estimated Revenue (Avg) | 10,988,100 | Research Access | Research Access | Research Access | Research Access |
| Estimated Ebitda (Low) | 2,687,704.474 | Research Access | Research Access | Research Access | Research Access |
| Estimated Ebitda (High) | 2,797,503.653 | Research Access | Research Access | Research Access | Research Access |
| Estimated Ebitda (Avg) | 2,734,003.247 | Research Access | Research Access | Research Access | Research Access |
| Estimated Net Income (Low) | 1,859,145.807 | Research Access | Research Access | Research Access | Research Access |
| Estimated Net Income (High) | 1,952,048.808 | Research Access | Research Access | Research Access | Research Access |
| Estimated Net Income (Avg) | 1,898,320.007 | Research Access | Research Access | Research Access | Research Access |
| Estimated SGA Expense (Low) | 2,485,267.230 | Research Access | Research Access | Research Access | Research Access |
| Estimated SGA Expense (High) | 2,580,336.929 | Research Access | Research Access | Research Access | Research Access |
| Estimated SGA Expense (Avg) | 2,525,355.144 | Research Access | Research Access | Research Access | Research Access |
| Estimated EPS (Avg) | 7.780 | Research Access | Research Access | Research Access | Research Access |
| Estimated EPS (High) | 8 | Research Access | Research Access | Research Access | Research Access |
| Estimated EPS (Low) | 7.620 | Research Access | Research Access | Research Access | Research Access |
| Number of Analysts (Estimated Revenue) | 5 | Research Access | Research Access | Research Access | Research Access |
| Number of Analysts (Estimated EPS) | 1 | Research Access | Research Access | Research Access | Research Access |
Log in to continue
Log in and subscribe to Full Access to see up to 5 years of analyst estimates.
Login — it's free(* All numbers are in thousands)
Current Key Metrics
Log in to continue
Log in to see all key valuation metrics and ratios for this symbol.
Login — it's freeForward P/E Ratios
Log in to continue
Log in with Full Access for forward P/E high/low estimates and the full multi-year table.
Login — it's freeSWOT Analysis
Strengths (preview)
- Strong Financial Performance: XYL has demonstrated robust revenue growth, as evidenced by recent income statements, with consistent increases in gross profit and operating income. Key metrics such as return on equity (ROE) and return on invested capital (ROIC) from the TTM data indicate efficient capital utilization and profitability compared to industry benchmarks.
- Healthy Cash Flow Generation: Cash flow statements highlight strong net cash provided by operating activities and positive free cash flow, reflecting XYL’s ability to fund operations and investments internally while maintaining financial flexibility.
- Solid Market Position: As part of the [industryName] within the [sectorName], XYL benefits from a stable market cap and consistent dividend yield (per TTM data), signaling reliability and attractiveness to income-focused investors.
Log in with Research Access for Weaknesses, Opportunities, Threats, and the complete SWOT.
At what price to buy it? -
Intrinsic Value Calculator
Based on current fundamentals and analyst forecasts, MarketSnap estimates XYL intrinsic value between $91.02 – $95.74 per share. This depends on revenue growth, margins, and discount rate.
This is an automatic estimate. The most reliable way to know fair value for your own assumptions is to run the calculator below.
Common questions about XYL valuation
Is XYL (XYL) overvalued or undervalued right now?
MarketSnap estimates intrinsic value for XYL (XYL) using its proprietary valuation methodology, which incorporates discounted cash flow (DCF) analysis together with long-term earnings and fundamentals assumptions. By comparing intrinsic value to the current market price, long-term investors can see whether the stock screens as potentially overvalued, fairly valued, or undervalued today.
Is XYL a buy, hold, or sell for long-term investors?
MarketSnap does not give one-word “buy” or “sell” calls. Instead, it shows whether XYL trades at a premium or discount to its estimated intrinsic value, how sensitive that value is to growth and margin assumptions, and how the stock fits into a diversified, long-term portfolio so investors can make their own buy, hold, or sell decision.
What is XYL’s P/E ratio?
You can see XYL’s trailing P/E (TTM) and forward P/E estimates in the Current Key Metrics and Forward P/E Ratios sections above. The P/E ratio compares the current share price to earnings per share and helps investors gauge valuation relative to earnings.
How is intrinsic value calculated for XYL?
MarketSnap uses its own valuation framework—not a generic spreadsheet DCF alone. Future cash flows and earnings are projected, discounted, and combined with MarketSnap’s methodology so intrinsic value reflects fundamentals and long-term assumptions. You can run your own inputs and see the result using the Intrinsic Value Calculator above.
Is XYL a good long-term investment?
Whether XYL fits a long-term portfolio depends on your assumptions about growth, margins, and risk. MarketSnap provides the metrics, intrinsic value calculator, and SWOT context so you can form your own view rather than rely on a single buy/sell rating.
XYL
1-day price chart preview. Log in for 1W through 5Y ranges and period tabs.
Daily snapshot
-0.05
Trading Metrics:
| Open: | — | Previous Close: | — | |
| Day Low: | — | Day High: | — | |
| Year Low: | Year High: | |||
| Price Avg 50: | Price Avg 200: | |||
| Volume: | Average Volume: |
Log in to continue
Log in for multi-period charts (1W–5Y), period tabs, and the same layout as members.
Login — it's free
